Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery-An Update. | Adv Med | 2023 | 36960081 | PubTator, text mining | PubMed |
| Roles and therapeutic implications of m6A modification in cancer immunotherapy. | Front Immunol | 2023 | 36960074 | PubTator, text mining | PubMed |
| SERPINE1 and its co-expressed genes are associated with the progression of clear cell renal cell carcinoma. | BMC Urol | 2023 | 36959648 | PubTator, text mining | PubMed |
| Immune response and drug therapy based on ac4C-modified gene in pancreatic cancer typing. | Front Immunol | 2023 | 36949954 | PubTator, text mining | PubMed |
| Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma. | Front Immunol | 2023 | 36949947 | PubTator, text mining | PubMed |
| Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma. | BMC Cancer | 2023 | 36949462 | PubTator, text mining | PubMed |
| Establishing a prognostic model of chromatin modulators and identifying potential drug candidates in renal clear cell patients. | BMC Bioinformatics | 2023 | 36941564 | PubTator, text mining | PubMed |
| Effect of a Fructose-Rich Diet on Gut Microbiota and Immunomodulation: Potential Factors for Multiple Sclerosis. | Immunohorizons | 2023 | 36939622 | PubTator, text mining | PubMed |
| Identification of the novel therapeutic targets and biomarkers associated of prostate cancer with cancer-associated fibroblasts (CAFs). | Front Oncol | 2023 | 36937411 | PubTator, text mining | PubMed |
| Platelets in the tumor microenvironment and their biological effects on cancer hallmarks. | Front Oncol | 2023 | 36937386 | PubTator, text mining | PubMed |
| Strategies for optimizing CITE-seq for human islets and other tissues. | Front Immunol | 2023 | 36936943 | PubTator, text mining | PubMed |
| Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies. | Front Immunol | 2023 | 36923402 | PubTator, text mining | PubMed |
| Identification of ferroptosis related biomarkers and immune infiltration in Parkinson's disease by integrated bioinformatic analysis. | BMC Med Genomics | 2023 | 36918862 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related long noncoding RNA for predicting prognostic and diagnostic value and immune landscape in colorectal adenocarcinoma. | Hum Genomics | 2023 | 36915193 | PubTator, text mining | PubMed |
| NFκB signaling in T cell memory. | Front Immunol | 2023 | 36911729 | PubTator, text mining | PubMed |
| A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response. | Front Pharmacol | 2023 | 36909185 | PubTator, text mining | PubMed |
| Overexpression of Potential Markers of Regulatory and Exhausted CD8+ T Cells in the Peripheral Blood Mononuclear Cells of Patients with B-Acute Lymphoblastic Leukemia. | Int J Mol Sci | 2023 | 36901957 | PubTator, text mining | PubMed |
| The construction of a novel ferroptosis-related lncRNA model to predict prognosis in colorectal cancer patients. | Medicine (Baltimore) | 2023 | 36897681 | PubTator, text mining | PubMed |
| Distinct roles of ADIPOR1 and ADIPOR2: A pan-cancer analysis. | Front Endocrinol (Lausanne) | 2023 | 36896172 | PubTator, text mining | PubMed |
| Integration of bulk RNA sequencing and single-cell analysis reveals a global landscape of DNA damage response in the immune environment of Alzheimer's disease. | Front Immunol | 2023 | 36895559 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=32